Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...

Peripheral Artery Disease I: Introduction

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Comparative Outcomes of Early versus Delayed Penile Prosthesis Insertion in Patients With Ischaemic Priapism-Long-Term Outcome Experience From a Single High-volume Centre.

Andrology·2026

Same author

Testosterone Therapy After Radical Prostatectomy: Insights From a Systematic Review and Meta-Analysis.

Andrology·2026

Same author

Ultrasound localisation microscopy tracks testicular microvascular adaptations to endocrine function in male infertility.

EBioMedicine·2026

Same author

Combination therapy for acute Peyronie' s disease: a success story of translation from bench to bedside.

Nature reviews. Urology·2026

Same author

A comparative evaluation of on-demand phosphodiesterase-5 inhibitor efficacy in erectile dysfunction treatment: a systematic review and network meta-analysis of double-blind, placebo-controlled, randomized trials.

The journal of sexual medicine·2026

Same author

Cosmetic Penile Enhancement Surgery and the Role of the Reconstructive Urologist.

European urology focus·2026

Search research articles

Related Experiment Video

Updated: Jul 3, 2026

Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease

Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease

Published on: March 15, 2024

Systemic vascular endothelial dysfunction in Peyronie's disease.

Vineet Agrawal¹, Elizabeth Ellins, Ann Donald

¹Institute of Urology, University College London, London, UK. agrawalvineet@hotmail.com

The Journal of Sexual Medicine

|July 22, 2008

Summary

Peyronie's disease (PD) is linked to systemic vascular changes, specifically impaired blood vessel function, even without typical atherosclerosis risk factors. This suggests broader health implications for PD patients requiring further investigation.

More Related Videos

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

Related Experiment Videos

Last Updated: Jul 3, 2026

Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease

Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease

Published on: March 15, 2024

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

Area of Science:

Cardiovascular Medicine
Urology
Vascular Biology

Background:

Peyronie's disease (PD) pathogenesis is unclear, though often associated with atherosclerosis risk factors and endothelial dysfunction.
Systemic vascular abnormalities are common in patients with atherosclerosis risk factors, potentially implicating vascular dysfunction in PD.
Investigating vascular dysfunction in PD offers a novel approach to understanding its causes.

Purpose of the Study:

To determine if Peyronie's disease (PD) is associated with systemic vascular changes.
To test the hypothesis that PD is linked to systemic vascular changes even in the absence of atherosclerosis risk factors.

Main Methods:

Vascular function assessed via high-resolution brachial artery ultrasound in 23 PD patients and 23 controls (aged 30-65) without atherosclerosis risk factors.
Measured endothelium-dependent, flow-mediated dilation (FMD) and endothelium-independent vasodilation (using glyceryl trinitrate).
Collected anthropometric data, blood pressure, fasting lipids, and glucose levels.

Main Results:

Endothelium-dependent flow-mediated dilation (FMD) was significantly impaired in PD patients compared to controls (5.62% vs. 7.46%, P=0.03).
Endothelium-independent vasodilation, blood pressure, lipids, and glucose levels were similar between groups.
Impaired FMD in PD patients persisted after multivariable adjustment for confounders.

Conclusions:

Patients with Peyronie's disease exhibit systemic conduit artery endothelial impairment, indicating broader vascular dysfunction.
These systemic vascular changes occur even without traditional risk factors for atherosclerosis and endothelial dysfunction.
The clinical relevance of these wider vascular abnormalities in PD warrants further investigation.